Thermo Fisher Scientific Inc (TMO) : Tuesdays money flow data in Thermo Fisher Scientific Inc (TMO) suggests that the bulls made the most of the weakness in the stock. The inflow of money into the stock on upticks was $38.53 million, whereas, $28.11 million worth of transactions were done on downticks. The ratio between the two, uptick and downtick stood at 1.37, in favor of the bulls. The total money flow into the stock was $10.43 million clearly indicating that the smart money has been buying into the stock on weakness.
In comparison, the money flow in block deals was $11.21 million. The total value of block trades done on upticks was $11.21 million. Thermo Fisher Scientific Inc (TMO) fell $0.35 and traded at $153.16, down -0.23% for the day, over previous days close. On a weekly basis, the shares are 0.53% over the previous weeks close.
Also, Equity Analysts at the Citigroup maintains the rating on Thermo Fisher Scientific Inc (NYSE:TMO). The brokerage firm has issued a Buy rating on the shares. The Analysts at the ratings agency raises the price target from $160 per share to $182 per share. The rating by the firm was issued on July 29, 2016.
Thermo Fisher Scientific, Inc. has lost 0.9% in the last five trading days and dropped 4.01% in the last 4 weeks. Thermo Fisher Scientific, Inc. is up 0.16% in the last 3-month period. Year-to-Date the stock performance stands at 8.2%.
Thermo Fisher Scientific Inc (NYSE:TMO): The stock opened at $153.80 on Tuesday but the bulls could not build on the opening and the stock topped out at $154.04 for the day. The stock traded down to $152.06 during the day, due to lack of any buying support eventually closed down at $153.16 with a loss of -0.23% for the day. The stock had closed at $153.51 on the previous day. The total traded volume was 966,456 shares.
In a related news,The director officer (Chief Executive Officer) of Thermo Fisher Scientific Inc., Casper Marc N sold 25,000 shares at $155.98 on August 15, 2016. The Insider selling transaction had a total value worth of $3,899,500. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Thermo Fisher Scientific Inc. is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments, provides instruments, consumables, software and services that are used in the laboratory; Specialty Diagnostics, offers diagnostic test kits, reagents, culture media, instruments and associated products, and Laboratory Products and Services, offers self-manufactured and sourced products for the laboratory.